We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

BY Editorial Team |May 28 2021

Laboratory scientists across the globe are invited to vote for their favorite clinical products of 2020. Here’s how.

We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

The 2021 Scientists Choice Awards®

SelectScience’s annual Scientists' Choice Awards is celebrating its 14th anniversary by honoring the most innovative and effective technologies of the past year. The awards provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to their work.

Thanks to our loyal customers, we’re delighted to announce the Access SARS-CoV-2 IgM assay > has been nominated in the Best New Clinical Assay/Kit of 2020 category.

Our high-sensitivity and high-specificity SARS-CoV-2 IgM assay > has market-leading accuracy with a high positive predictive value (PPV) and a high negative predictive value (NPV). This provides clinicians with useful immune response information and may help determine if their patients have had a recent COVID-19 infection.

Casting Your Vote

Voting closes Sunday, June 13, 2021. All scientists who cast their vote for their favorite clinical products of 2020 will be entered into a drawing for a chance to win a $500/£400/450 € Amazon Gift Card from SelectScience.

Interested in sharing your thoughts?

Vote now

Editorial Team

The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

See all by Editorial Team

HIV Clinical Insights: From Lab to Patient Care

BY Dr. Lindsay Sun, M.D., M.S. |July 10 2025

5 min read

HIV remains a significant public health concern worldwide, and diagnosis can be complicated. HIV presents with many of the same symptoms as other viral conditions, including COVID and the flu. Social (stigma), financial (cost), personal (fear) and system-wide (access) barriers exist for patients in need of testing. The time requirements to test for antibodies in the blood, and the layered nature of many current testing protocols influence the duration from exposure to diagnosis and treatment

Sickle Cell 101: Increasing Awareness and Understanding

BY Ahmed Bentahar, M.D., Ph.D. |June 19 2025

3 min read

In honor of World Sickle Cell Awareness Day, we recognize Sickle Cell Disease, a condition that disproportionately affects people of African descent 1,2

Advancing Your Clinical Capabilities

BY Matt Maxfield |May 23 2025

5 min read

Explore real-world examples of how our solutions are helping advance clinical capabilities every day, all around the world.

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

All trademarks used herein are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language